Form 4: Amgen Director Charles M. Holley Reports Acquisition of Common Stock

Director Charles M. Holley reports acquiring 719 shares of Amgen common stock and holding 9,574.0209 shares following the transaction on May 31, 2024.

Summary

• On May 31, 2024, Charles M. Holley, a director of Amgen Inc., acquired 719 shares of common stock.
• The acquisition was made through the vesting of Restricted Stock Units (RSUs) granted under the Amgen Inc. 2009 Director Incentive Program.
• The RSUs vested immediately and are paid in shares of Amgen's common stock on a one-to-one basis.
• Holley also holds 1,260 shares indirectly through the Holley Family Trust.
• Following the reported transaction, Holley beneficially owns 9,574.0209 shares of Amgen common stock directly, which includes 912 Dividend Equivalents (DEs).

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing detailing stock transactions. The acquisition of shares by a director is generally viewed positively, but the document itself is purely informational.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements, but it implies continued participation in Amgen's equity incentive plans by the director.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders and their holdings in the company's stock.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates